China Paclitaxel Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Paclitaxel Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Paclitaxel Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Paclitaxel Overall Market Size
2.1 China Paclitaxel Market Size: 2021 VS 2027
2.2 China Paclitaxel Revenue, Prospects & Forecasts: 2016-2027
2.3 China Paclitaxel Sales: 2016-2027
3 Company Landscape
3.1 Top Paclitaxel Players in China Market
3.2 Top China Paclitaxel Companies Ranked by Revenue
3.3 China Paclitaxel Revenue by Companies
3.4 China Paclitaxel Sales by Companies
3.5 China Paclitaxel Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Paclitaxel Companies in China Market, by Revenue in 2020
3.7 Manufacturers Paclitaxel Product Type
3.8 Tier 1, Tier 2 and Tier 3 Paclitaxel Players in China Market
3.8.1 List of Tier 1 Paclitaxel Companies in China
3.8.2 List of Tier 2 and Tier 3 Paclitaxel Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Paclitaxel Market Size Markets, 2021 & 2027
4.1.2 Natural Paclitaxel API
4.1.3 Semi-synthetic Paclitaxel API
4.2 By Type - China Paclitaxel Revenue & Forecasts
4.2.1 By Type - China Paclitaxel Revenue, 2016-2021
4.2.2 By Type - China Paclitaxel Revenue, 2022-2027
4.2.3 By Type - China Paclitaxel Revenue Market Share, 2016-2027
4.3 By Type - China Paclitaxel Sales & Forecasts
4.3.1 By Type - China Paclitaxel Sales, 2016-2021
4.3.2 By Type - China Paclitaxel Sales, 2022-2027
4.3.3 By Type - China Paclitaxel Sales Market Share, 2016-2027
4.4 By Type - China Paclitaxel Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Paclitaxel Market Size, 2021 & 2027
5.1.2 Ovarian Cancer
5.1.3 Cervical Cancer
5.1.4 Breast Cancer
5.1.5 Others
5.2 By Application - China Paclitaxel Revenue & Forecasts
5.2.1 By Application - China Paclitaxel Revenue, 2016-2021
5.2.2 By Application - China Paclitaxel Revenue, 2022-2027
5.2.3 By Application - China Paclitaxel Revenue Market Share, 2016-2027
5.3 By Application - China Paclitaxel Sales & Forecasts
5.3.1 By Application - China Paclitaxel Sales, 2016-2021
5.3.2 By Application - China Paclitaxel Sales, 2022-2027
5.3.3 By Application - China Paclitaxel Sales Market Share, 2016-2027
5.4 By Application - China Paclitaxel Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Phyton
6.1.1 Phyton Corporation Information
6.1.2 Phyton Overview
6.1.3 Phyton Paclitaxel Sales and Revenue in China Market (2016-2021)
6.1.4 Phyton Paclitaxel Product Description
6.1.5 Phyton Recent Developments
6.2 ScinoPharm
6.2.1 ScinoPharm Corporation Information
6.2.2 ScinoPharm Overview
6.2.3 ScinoPharm Paclitaxel Sales and Revenue in China Market (2016-2021)
6.2.4 ScinoPharm Paclitaxel Product Description
6.2.5 ScinoPharm Recent Developments
6.3 Novasep
6.3.1 Novasep Corporation Information
6.3.2 Novasep Overview
6.3.3 Novasep Paclitaxel Sales and Revenue in China Market (2016-2021)
6.3.4 Novasep Paclitaxel Product Description
6.3.5 Novasep Recent Developments
6.4 Samyang
6.4.1 Samyang Corporation Information
6.4.2 Samyang Overview
6.4.3 Samyang Paclitaxel Sales and Revenue in China Market (2016-2021)
6.4.4 Samyang Paclitaxel Product Description
6.4.5 Samyang Recent Developments
6.5 Polymed
6.5.1 Polymed Corporation Information
6.5.2 Polymed Overview
6.5.3 Polymed Paclitaxel Sales and Revenue in China Market (2016-2021)
6.5.4 Polymed Paclitaxel Product Description
6.5.5 Polymed Recent Developments
6.6 TAPI (Teva)
6.6.1 TAPI (Teva) Corporation Information
6.6.2 TAPI (Teva) Overview
6.6.3 TAPI (Teva) Paclitaxel Sales and Revenue in China Market (2016-2021)
6.6.4 TAPI (Teva) Paclitaxel Product Description
6.6.5 TAPI (Teva) Recent Developments
6.7 Fresenius-kabi
6.7.1 Fresenius-kabi Corporation Information
6.7.2 Fresenius-kabi Overview
6.7.3 Fresenius-kabi Paclitaxel Sales and Revenue in China Market (2016-2021)
6.7.4 Fresenius-kabi Paclitaxel Product Description
6.7.5 Fresenius-kabi Recent Developments
6.8 Huiang biopharma
6.8.1 Huiang biopharma Corporation Information
6.8.2 Huiang biopharma Overview
6.8.3 Huiang biopharma Paclitaxel Sales and Revenue in China Market (2016-2021)
6.8.4 Huiang biopharma Paclitaxel Product Description
6.8.5 Huiang biopharma Recent Developments
6.9 Southpharma
6.9.1 Southpharma Corporation Information
6.9.2 Southpharma Overview
6.9.3 Southpharma Paclitaxel Sales and Revenue in China Market (2016-2021)
6.9.4 Southpharma Paclitaxel Product Description
6.9.5 Southpharma Recent Developments
6.10 Yunnan Hande
6.10.1 Yunnan Hande Corporation Information
6.10.2 Yunnan Hande Overview
6.10.3 Yunnan Hande Paclitaxel Sales and Revenue in China Market (2016-2021)
6.10.4 Yunnan Hande Paclitaxel Product Description
6.10.5 Yunnan Hande Recent Developments
6.11 Hainan Yew Pharm
6.11.1 Hainan Yew Pharm Corporation Information
6.11.2 Hainan Yew Pharm Overview
6.11.3 Hainan Yew Pharm Paclitaxel Sales and Revenue in China Market (2016-2021)
6.11.4 Hainan Yew Pharm Paclitaxel Product Description
6.11.5 Hainan Yew Pharm Recent Developments
6.12 Jiangsu Yew Biotechnology
6.12.1 Jiangsu Yew Biotechnology Corporation Information
6.12.2 Jiangsu Yew Biotechnology Overview
6.12.3 Jiangsu Yew Biotechnology Paclitaxel Sales and Revenue in China Market (2016-2021)
6.12.4 Jiangsu Yew Biotechnology Paclitaxel Product Description
6.12.5 Jiangsu Yew Biotechnology Recent Developments
7 China Paclitaxel Production Capacity, Analysis
7.1 China Paclitaxel Production Capacity, 2016-2027
7.2 Paclitaxel Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Paclitaxel Supply Chain Analysis
9.1 Paclitaxel Industry Value Chain
9.2 Paclitaxel Upstream Market
9.3 Paclitaxel Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Paclitaxel Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Paclitaxel in China Market
Table 2. Top Paclitaxel Players in China Market, Ranking by Revenue (2019)
Table 3. China Paclitaxel Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Paclitaxel Revenue Share by Companies, 2016-2021
Table 5. China Paclitaxel Sales by Companies, (Kg), 2016-2021
Table 6. China Paclitaxel Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Paclitaxel Price (2016-2021) & (USD/Kg)
Table 8. Manufacturers Paclitaxel Product Type
Table 9. List of Tier 1 Paclitaxel Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Paclitaxel Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Natural Paclitaxel API
Table 12. Major Manufacturers of Semi-synthetic Paclitaxel API
Table 13. By Type - China Paclitaxel Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Paclitaxel Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Paclitaxel Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Paclitaxel Sales (Kg), 2016-2021
Table 17. By Type - China Paclitaxel Sales (Kg), 2022-2027
Table 18. By Application - China Paclitaxel Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Paclitaxel Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Paclitaxel Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Paclitaxel Sales (Kg), 2016-2021
Table 22. By Application - China Paclitaxel Sales (Kg), 2022-2027
Table 23. Phyton Corporation Information
Table 24. Phyton Description and Major Businesses
Table 25. Phyton Paclitaxel Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 26. Phyton Paclitaxel Product
Table 27. Phyton Recent Developments
Table 28. ScinoPharm Corporation Information
Table 29. ScinoPharm Description and Major Businesses
Table 30. ScinoPharm Paclitaxel Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 31. ScinoPharm Paclitaxel Product
Table 32. ScinoPharm Recent Developments
Table 33. Novasep Corporation Information
Table 34. Novasep Description and Major Businesses
Table 35. Novasep Paclitaxel Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 36. Novasep Paclitaxel Product
Table 37. Novasep Recent Developments
Table 38. Samyang Corporation Information
Table 39. Samyang Description and Major Businesses
Table 40. Samyang Paclitaxel Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 41. Samyang Paclitaxel Product
Table 42. Samyang Recent Developments
Table 43. Polymed Corporation Information
Table 44. Polymed Description and Major Businesses
Table 45. Polymed Paclitaxel Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 46. Polymed Paclitaxel Product
Table 47. Polymed Recent Developments
Table 48. TAPI (Teva) Corporation Information
Table 49. TAPI (Teva) Description and Major Businesses
Table 50. TAPI (Teva) Paclitaxel Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 51. TAPI (Teva) Paclitaxel Product
Table 52. TAPI (Teva) Recent Developments
Table 53. Fresenius-kabi Corporation Information
Table 54. Fresenius-kabi Description and Major Businesses
Table 55. Fresenius-kabi Paclitaxel Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 56. Fresenius-kabi Paclitaxel Product
Table 57. Fresenius-kabi Recent Developments
Table 58. Huiang biopharma Corporation Information
Table 59. Huiang biopharma Description and Major Businesses
Table 60. Huiang biopharma Paclitaxel Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 61. Huiang biopharma Paclitaxel Product
Table 62. Huiang biopharma Recent Developments
Table 63. Southpharma Corporation Information
Table 64. Southpharma Description and Major Businesses
Table 65. Southpharma Paclitaxel Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 66. Southpharma Paclitaxel Product
Table 67. Southpharma Recent Developments
Table 68. Yunnan Hande Corporation Information
Table 69. Yunnan Hande Description and Major Businesses
Table 70. Yunnan Hande Paclitaxel Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 71. Yunnan Hande Paclitaxel Product
Table 72. Yunnan Hande Recent Developments
Table 73. Hainan Yew Pharm Corporation Information
Table 74. Hainan Yew Pharm Description and Major Businesses
Table 75. Hainan Yew Pharm Paclitaxel Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 76. Hainan Yew Pharm Paclitaxel Product
Table 77. Hainan Yew Pharm Recent Developments
Table 78. Jiangsu Yew Biotechnology Corporation Information
Table 79. Jiangsu Yew Biotechnology Description and Major Businesses
Table 80. Jiangsu Yew Biotechnology Paclitaxel Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 81. Jiangsu Yew Biotechnology Paclitaxel Product
Table 82. Jiangsu Yew Biotechnology Recent Developments
Table 83. Paclitaxel Production Capacity (Kg) of Key Manufacturers in China Market, 2019-2021 (Kg)
Table 84. China Paclitaxel Capacity Market Share of Key Manufacturers, 2019-2021
Table 85. Paclitaxel Market Opportunities & Trends in China Market
Table 86. Paclitaxel Market Drivers in China Market
Table 87. Paclitaxel Market Restraints in China Market
Table 88. Paclitaxel Raw Materials
Table 89. Paclitaxel Raw Materials Suppliers in China Market
Table 90. Typical Paclitaxel Downstream
Table 91. Paclitaxel Downstream Clients in China Market
Table 92. Paclitaxel Distributors and Sales Agents in China Market
List of FiguresFigure 1. Paclitaxel Product Picture
Figure 2. Paclitaxel Segment by Type
Figure 3. Paclitaxel Segment by Application
Figure 4. China Paclitaxel Market Overview: 2020
Figure 5. China Paclitaxel Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Paclitaxel Revenue, 2016-2027 (US$, Mn)
Figure 7. Paclitaxel Sales in China Market: 2016-2027 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Paclitaxel Revenue in 2020
Figure 9. Natural Paclitaxel API Product Picture
Figure 10. Semi-synthetic Paclitaxel API Product Picture
Figure 11. By Type - China Paclitaxel Sales Market Share, 2016-2027
Figure 12. By Type - China Paclitaxel Revenue Market Share, 2016-2027
Figure 13. By Type - China Paclitaxel Price (USD/Kg), 2016-2027
Figure 14. Ovarian Cancer
Figure 15. Cervical Cancer
Figure 16. Breast Cancer
Figure 17. Others
Figure 18. By Application - China Paclitaxel Sales Market Share, 2016-2027
Figure 19. By Application - China Paclitaxel Revenue Market Share, 2016-2027
Figure 20. By Application - China Paclitaxel Price (USD/Kg), 2016-2027
Figure 21. Phyton Paclitaxel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. ScinoPharm Paclitaxel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Novasep Paclitaxel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Samyang Paclitaxel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Polymed Paclitaxel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. TAPI (Teva) Paclitaxel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Fresenius-kabi Paclitaxel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Huiang biopharma Paclitaxel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Southpharma Paclitaxel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Yunnan Hande Paclitaxel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Hainan Yew Pharm Paclitaxel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Jiangsu Yew Biotechnology Paclitaxel Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. China Paclitaxel Production Capacity (Kg), 2016-2027
Figure 34. Paclitaxel Industry Value Chain
Figure 35. Marketing Channels